Join to View Full Profile
1301 Medical Center DrNashville, TN 37232
Phone+1 615-936-2000
Fax+1 615-936-0605
Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elizabeth Davis is an oncologist in Nashville, TN and is affiliated with Vanderbilt University. She has been in practice for 10 years and specializes in the treatment of patients with bone and soft tissue sarcoma.
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2012 - 2015- University of MichiganResidency, Internal Medicine, 2009 - 2012
Wright State University Boonshoft School of MedicineClass of 2009
Duke UniversityBS, Biology, 2004
Certifications & Licensure
TN State Medical License 2016 - 2026
AL State Medical License 2020 - 2020
MI State Medical License 2015 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Localized Leiomyosarcoma Biomarker Protocol Start of enrollment: 2023 Apr 26
- 9-ING-41 in Patients with Advanced Cancers Start of enrollment: 2019 Jan 04
Roles: Contact
- To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue Start of enrollment: 2021 Sep 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Prevalence and Associated Factors for Depression Among Patients With Sarcoma.Michael J Robinson, Sang Minh Nguyen, Debra L Friedman, Emma A Schremp, Lucy L Wang
JCO Oncology Practice. 2025-03-04 - Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer ...Michael Cecchini, Mary Jo Pilat, Nataliya Uboha, Nilofer S Azad, May Cho
Cancer. 2025-02-15 - Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.Aung Naing, Amit Mahipal, Milind Javle, Judy Wang, Todd M Bauer
Journal of Immunotherapy and Precision Oncology. 2025-02-01
Professional Memberships
- Member
- Connective Tissue Oncology SocietyMember
- Sarcoma Alliance for Research through CollaborationMember
- Member
- Children's Oncology GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
